Mechanisms of protein quality control in health and disease

About the project

About the Project The accumulation of misfolded proteins and aberrant protein aggregates is a hallmark of numerous human diseases, including neurodegenerative disorders and cancer. Under normal conditions, potentially toxic proteins are kept at low levels by sophisticated quality control systems that recognize damaged or misfolded proteins and target them for degradation. Our laboratory investigates these protein quality control pathways, with a particular focus on endoplasmic reticulum-associated degradation (ERAD), which monitors the quality of membrane and secreted proteins. ERAD is an evolutionarily conserved pathway that regulates the turnover of thousands of proteins in mammalian cells, influencing diverse cellular processes including lipid metabolism, stress responses, cell signaling, and intercellular communication. Defects in ERAD have been linked to a wide range of human diseases, highlighting its central role in cellular homeostasis. We study ERAD using multidisciplinary approaches in both human and yeast model systems. By combining CRISPR-based genome-wide genetic screens, advanced fluorescence microscopy, biochemistry, and structural biology, we seek to uncover the molecular mechanisms that control the recognition and degradation of disease-relevant proteins. Our work has revealed previously unrecognized roles for ERAD in maintaining endoplasmic reticulum homeostasis, organizing the nuclear envelope, and regulating lipid metabolism. Our research is driven by fundamental biological questions while maintaining strong relevance to human health. Students joining the lab will have the opportunity to work at the interface of cell biology, genetics, biochemistry, and structural biology, contributing to discoveries that may ultimately inform new therapeutic strategies for protein-misfolding diseases.

Research areas